Stock market today: S&P 500 climbs as health care, tech gain; Nvidia earnings loom
He Junli, CEO of Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HRGN), recently acquired 2,299 shares of the company's common stock. The shares were purchased at an average price of $2.87 per share, bringing the total transaction value to approximately $6,598. According to InvestingPro data, the stock is currently trading slightly below its Fair Value, with a beta of -1.18 indicating movement typically opposite to the market. Following this purchase, Junli's total direct holdings amount to 262,000 shares. The transactions occurred between December 24 and December 30, 2024. With a market capitalization of $47.44 million and a strong current ratio of 3.19, InvestingPro analysis reveals 8 additional key insights about HRGN's financial position and market performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.